Several studies have reported elevated serum and CSF biomarkers indicating neurologic injury in COVID-19 patients [18,21,26], with significantly higher plasma NfL levels observed in COVID-19 patients when compared to healthy controls [27]. This evidence concerns the gene NEFL and COVID-19.